Financial Data and Key Metrics Changes - Revenue for Q2 2026 increased by 4.3% to $42 million compared to $40.2 million in the same quarter last year [14] - Gross profit decreased to $6.3 million from $7.1 million, with gross profit margin declining to 15% from 17.5% [15] - Operating income slightly decreased to $1.09 million from $1.13 million [16] - Net income was $479,000 or $0.04 per diluted share, down from $665,000 or $0.05 per diluted share in the prior year [16] - Comprehensive income attributable to common stockholders decreased to $440,000 from $663,000 [17] - Cash and restricted cash totaled $13.7 million, with net working capital at $35.2 million [17] - Net cash provided by operating activities was approximately $318,000, down from $2.4 million in the same period last year [18] Business Line Data and Key Metrics Changes - The company successfully completed the expansion of manufacturing facilities, increasing production capacity by approximately 15% [6] - The diversification of the customer base and product mix is aimed at enhancing year-round production stability [7] Market Data and Key Metrics Changes - Jordan is increasingly recognized as a preferred manufacturing hub due to favorable tariff rates compared to other sourcing countries [5] - Apparel exports from Jordan to the U.S. benefit from a 15% tariff, significantly lower than rates from other countries [5] Company Strategy and Development Direction - The company is focusing on long-term expansion plans, including potential acquisitions and developing its own land [6] - The strategy includes diversifying the customer base and product mix to reduce seasonality impacts [7] - The goal is to gradually improve gross profit margins to approximately 20% through increased automation and economies of scale [8] Management's Comments on Operating Environment and Future Outlook - Management remains vigilant about regional geopolitical uncertainties and tariff developments while advancing growth strategies [8] - Revenue for Q3 2026 is expected to increase by 19% to 21% compared to the same quarter last year, with gross margin anticipated to be approximately 13% to 15% [19] Other Important Information - The Board of Directors approved a regular quarterly dividend of $0.05 per share payable on November 26, 2025 [18] Q&A Session Summary Question: Revenue guidance for the third quarter breakdown - The company does not break down revenue guidance by capacity increase versus demand increase, but overall capacity has increased by about 10% to 15% [22] Question: Path to improving gross margins to 20% - Management indicated that achieving a 20% gross margin is a long-term goal that will take a few years, with current margins expected to remain flat or lower due to new customer onboarding [24][25] Question: Context on inventory increase - Inventory is up 30% year-over-year due to preparing for a large volume customer, which is atypical for the season [30] Question: Expansion plans and customer details - Expansion is driven by both existing and new customers, with significant orders from legacy customers and new partnerships [35][36] Question: Tariff impact and customer sourcing - Customers are shifting orders from countries like China and India to Jordan due to lower tariffs, enhancing the company's competitive position [40][42] Question: Q4 performance expectations - Q4 is expected to be better than previous years, with full booking through February indicating a strong demand outlook [46]

Financial Data and Key Metrics Changes - The company reported a net sales decline of 1.3% for Q3, an improvement from a 5.2% decline in the first half of the year [38][39] - Gross margin for Q3 was 59.6%, up 30 basis points year-over-year and 60 basis points from the previous quarter [6][45] - Adjusted EBITDA for the quarter was $143 million, with an adjusted EBITDA margin of 16.3% [39][46] - Adjusted net income was reported at $64 million [39] Business Line Data and Key Metrics Changes - Direct-to-consumer (D2C) sales increased by 3.5% period over period, with D2C e-commerce up over 10% [4][5] - Non-travel sales grew almost 7% in Q3, representing a significant opportunity for the company [6][50] - Wholesale channel net sales declined by 4.5%, with traditional brick-and-mortar sales down around 7% [5][40] Market Data and Key Metrics Changes - North America saw a net sales decline of 10%, although TUMI brand improved by 3.3% in Q3 [11][42] - Asia's net sales were roughly flat, with TUMI showing a 7.1% increase in Q3 [40][42] - Europe reported a 1% increase in sales, while Latin America grew by 1.2% [40][44] Company Strategy and Development Direction - The company is focused on capitalizing on growth in travel and expanding its non-travel business, which has shown a 14% CAGR from 2020 to 2025 [10][26] - There is a strong emphasis on product innovation and enhancing brand awareness across all brands [18][19] - The company plans to complete a dual listing in the U.S. by 2026 to enhance shareholder value [61][62] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in medium and long-term sales growth despite current macroeconomic uncertainties [57] - Positive trends in consumer demand for travel are expected to continue, with strong product launches anticipated for Q4 [57][58] - The company is well-positioned to maintain strong gross margins due to effective tariff mitigation strategies [59][60] Other Important Information - The company has successfully refinanced its corporate debt, extending maturities and improving liquidity [53][54] - The DTC sales mix has increased to 42%, with e-commerce channels growing significantly [49][50] - The company has opened 43 net new stores over the past year, impacting G&A expenses [46] Q&A Session Summary Question: Can you provide insights on the performance of TUMI in North America? - TUMI showed a positive growth of 3.3% in Q3, a significant improvement from a decline of 3.3% in Q2 [42] Question: What are the expectations for the non-travel segment? - The non-travel segment is expected to continue growing, with a reported 6.7% growth in Q3 and representing 35.6% of total sales [50][51] Question: How is the company managing its cost structure amid current challenges? - The company has maintained a disciplined approach to managing its cost structure, with gross margins remaining strong despite tariff impacts [45][46]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 reached $45.6 million, up 25% year over year, or up 22% on a constant currency basis [18] - Adjusted EBITDA loss improved to $14 million compared to $17 million in the same quarter last year [10] - Loss before income tax was $17.7 million, a 1% decrease year over year [10][24] Business Line Data and Key Metrics Changes - Physical goods GMV grew by 26% year over year, and by 37% when excluding corporate sales [4][7] - First-party sales increased by 54% year over year, driven by strong momentum with key international brands [20] - Marketing and advertising revenue totaled $1.3 million, down 24% year over year [19] Market Data and Key Metrics Changes - Active customers increased by 22% year over year, marking the highest increase in the past three years [7] - Orders from up-country regions represented 60% of total volume this quarter, up from 54% in the same quarter last year [11] - Nigeria's physical goods orders were up 30% year over year, while Kenya saw a 56% increase [12][13] Company Strategy and Development Direction - The company aims to achieve full-year profitability by 2027, focusing on efficiency, disciplined execution, and strategic investments [5][27] - Jumia is phasing out non-core digital transactions to streamline operations and enhance efficiency [6] - The company is expanding its logistics and commercial infrastructure to serve secondary cities and rural regions [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year guidance, citing strong customer demand and operational improvements [9][27] - The competitive environment remains stable, with some global entrants pulling back in markets like Nigeria [16] - Management highlighted the importance of adapting to local market conditions to maintain a competitive edge [55] Other Important Information - The average order value for physical goods in Q3 2025 was $35, down from $38 in Q3 2024 [8] - The total headcount declined by 7% since December 2024, reflecting a leaner organization [10] - The liquidity position at the end of Q3 was $82.5 million, including $81.5 million in cash [24] Q&A Session Summary Question: Guidance for PBT and cost management - Management expects significant acceleration in usage in Q4 due to strong seasonality, with further growth in usage likely to bring economies of scale on fulfillment costs [33][34] Question: Working capital movements for Q4 - Management indicated that they do not expect significant changes in working capital dynamics for Q4, as they can ramp up inventory much faster now [36][39] Question: October order and GMV growth - Management confirmed that the above 30% growth in October reflects continued momentum, but they remain cautious about setting expectations for the entire quarter [42][43] Question: Competitive environment and supply access - Management noted that international platforms are facing challenges in Africa due to operational difficulties, while Jumia's localized model provides a competitive advantage [52][55] Question: Advertising monetization opportunities - Management sees significant upside potential in advertising revenue, aiming to reach around 2% of GMV in the future, driven by better tools and execution [87][88]

Financial Data and Key Metrics Changes - The company reported a GMV of $37.8 billion for Q3 2025, reflecting a 9% year-over-year increase, and $108.4 billion for the first nine months, showing a 7% increase year-over-year [12] - Q3 revenue reached a record $81.9 million, up 4% year-over-year, while revenue for the first nine months was $245.3 million, increasing 5% year-over-year [13] - Non-GAAP gross profit for Q3 was $41.5 million, a 5% year-over-year increase, translating to a non-GAAP gross profit margin of approximately 51%, up 1% from the previous year [16] - Adjusted EBITDA for Q3 was $5.6 million, representing a margin of approximately 7%, with expectations for a margin of approximately 15% in Q4 [18][21] Business Line Data and Key Metrics Changes - The money transfer and payments category grew 100% year-over-year in Q3, driven by new business activity [14] - The tickets and travel category grew 6% in Q3, while the fashion and luxury category saw a 13% increase [13][14] - The home category contracted by approximately 70% year-over-year, but growth is expected to return in Q4 [15] Market Data and Key Metrics Changes - In the U.S., revenue declined 12% year-over-year, primarily due to the contraction in the home category [15] - APAC region grew approximately 55% year-over-year, while other Americas (Canada and Latin America) grew approximately 18% year-over-year [15][16] - EMEA region experienced a 19% year-over-year growth, with strong performance in fashion and luxury, tickets and travel, and money transfer and payments [16] Company Strategy and Development Direction - The company is focused on enhancing machine learning capabilities and has shifted approximately 70% of its models to autonomous training, which is expected to improve scalability and performance [6][7] - The company is investing in new product developments, including Adaptive Checkout, which has shown significant improvements in conversion rates for merchants [9] - The strategy includes targeting specific verticals and geographic regions for expansion, with a focus on mid-market opportunities [26] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for the upcoming holiday season, supported by resilient consumer spending and strong performance in key categories [10][11] - The company raised the bottom end of its revenue guidance for the second consecutive quarter, now anticipating revenue between $338 million and $346 million for the full year [21] - Management highlighted the importance of navigating complexities introduced by agentic commerce and stablecoin adoption, positioning the company to assist merchants in this evolving landscape [39][60] Other Important Information - The company ended Q3 with $325 million in cash and investments, maintaining a zero-debt position [19] - Share repurchase activity included 5.2 million shares for approximately $25.3 million in Q3, with a total of 14.2 million shares repurchased for about $69.2 million in the first nine months [20] Q&A Session Summary Question: Momentum as the year ends - Management expects strong performance from both upselling existing merchants and acquiring new clients [24] Question: Emerging verticals for 2026 - The company is focused on specific large verticals and geographic regions for expansion, considering both product and distribution strategies [25][26] Question: Revenue contribution from non-Chargeback Guarantee products - Non-Chargeback Guarantee products have shown strong growth, exceeding 100% [29] Question: Long-term margin profile - The long-term margin profile varies based on product mix, with a focus on increasing gross profit dollars [30] Question: Gross margin trajectory into next year - Recent model improvements are expected to enhance gross margins, despite potential headwinds from new categories [34][35] Question: One-time expense impacts in Q3 - Positive impacts were related to payroll adjustments and reserve duties, with expectations for operating expenses to be around $39 million in Q4 [36][37] Question: Growing stablecoin adoption - The company sees stablecoins introducing complexity for merchants, which could drive demand for its services [39] Question: Agentic commerce opportunities and threats - Agentic commerce could increase demand for services due to added complexity, but could also pose risks if transactions shift away from traditional e-commerce [58][60] Question: 2026 EBITDA targets - Management remains optimistic about achieving targeted margins, although some delays may occur due to merchant events [62]

Financial Data and Key Metrics Changes - In Q3 2025, net product revenue was $21.1 million, slightly up from $20.9 million in Q2 2025 [29] - Deferred revenue at the end of Q3 was $7.6 million, compared to $2.1 million in Q2 2025, indicating a healthy backlog of products ready for infusion [29] - The net loss for Q3 2025 was $79.1 million, reduced from a loss of $82.1 million in Q3 2024 [31] Business Line Data and Key Metrics Changes - AUCATZYL achieved $21.1 million in net sales for Q3 2025, with total sales of $51 million for the first nine months of the year [8][29] - The manufacturing success rate exceeded 90%, and patient access was achieved for over 90% of U.S. covered lives [9] Market Data and Key Metrics Changes - The CAR-T market share for the treatment of relapsed refractory B-ALL was approximately 15% before AUCATZYL's commercialization, increasing to around 20% within the 60 treatment centers currently active [10] Company Strategy and Development Direction - The company aims to drive market share in adult ALL, improve margins, and expand beyond ALL into pediatric ALL and other indications [8][33] - The focus is on optimizing operations and leveraging investments in infrastructure to enhance efficiencies [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing commercial launch of AUCATZYL, highlighting positive feedback from physicians and the potential for growth in the CAR-T market [5][10] - The company is preparing for upcoming data presentations at ASH and expects to initiate pivotal studies in lupus nephritis and pediatric ALL [33] Other Important Information - The company has made key leadership changes to strengthen its operational capabilities, including the appointment of a new Chief Technology Officer and Chief Commercial Officer [12][13] Q&A Session Summary Question: Can you talk about the patient flow and anticipated patient flow going forward? - Management noted a good proportion of patients were not initially considered for CAR-T therapy, indicating an expansion of market penetration [35][37] Question: What is the competitive positioning for obe-cel in pediatric patients? - The focus is on high-risk pediatric patients who currently have limited options, with a strong safety and efficacy profile for obe-cel [39][41] Question: Can you provide insights on the Q3 performance and expectations for Q4? - Management indicated that Q3 performance was impacted by CMS reimbursement policy changes, but they expect a healthy amount of deferred revenue for Q4 [46][50] Question: What are the growth opportunities in the CAR-T market? - The majority of patients are not yet receiving CAR-T therapy, presenting significant growth opportunities within existing treatment centers [58][60] Question: What data is expected at ASH? - Key data points will include pediatric ALL study results and expanded data from the CARLYSLE study, focusing on safety and efficacy [68][70]

Financial Data and Key Metrics Changes - Total revenues for Q3 2025 were $12 million, down from $13.3 million in the prior year [19] - Product revenues decreased to $10.7 million from $10.9 million in Q3 2024, primarily due to a decline in revenues from pilot helmets and training products [20] - Net income for Q3 2025 was $4.1 million, or $0.02 per share, compared to a net loss of $3.5 million, or $0.03 per share in Q3 2024 [21] Business Line Data and Key Metrics Changes - Funded research and development revenues decreased to $1.2 million from $2.3 million in Q3 2024, mainly due to project completion timing [20] - Cost of product revenue was $8.4 million, or 79% of net product revenues, compared to $8.3 million, or 76% in the prior year [20] - R&D expenses were $2.5 million, a slight decrease from the previous year, attributed to reduced spending on U.S. defense programs [21] Market Data and Key Metrics Changes - The U.S. Army aims to purchase at least 1 million drones in the next two to three years, significantly increasing demand compared to the current annual purchase of approximately 50,000 drones [9] - The first-person drone market is projected to grow from under $300 million last year to as much as $1.2 billion by 2030, representing a compound annual growth rate of around 31% [9] Company Strategy and Development Direction - The company has entered strategic partnerships with organizations like Ondas Holdings and Theon International, enhancing its position in the defense sector [5][7] - Kopin aims to leverage increased defense budgets and modernization efforts globally, particularly in Europe and NATO countries [7][14] - The company is focusing on high-demand areas such as thermal weapon sights and armored vehicle applications, with a strong opportunity pipeline exceeding $1 billion [10][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue and profitability goals for 2027 and 2028, supported by a strong pipeline and ongoing defense spending [14] - The geopolitical landscape is expected to drive continued growth in defense spending, with a focus on providing advanced technologies for military applications [15] - Management highlighted a transformation within the company, emphasizing improved quality, customer relationships, and a solid capital structure [16][17] Other Important Information - The company has successfully addressed quality issues in manufacturing, achieving some of the highest quality scores in its history [16] - A recent legal judgment resulted in a lower-than-expected liability, allowing the company to focus on growth and operational improvements [16] Q&A Session Summary Question: Any developments on neural display? - The company demonstrated a bidirectional microdisplay that allows drone control using eye movement, indicating a commitment to invest in this technology [28][29] Question: What should be expected regarding quarterly OpEx? - The company anticipates that spending will remain consistent with previous quarters, with a focus on growth [30][31] Question: Can you size the near-term opportunities in the pipeline? - The company has approximately 80% of the backlog needed to meet its 2026 plan, with strong visibility on major programs until 2030 [35][36] Question: Update on Kopin One initiatives and automation? - The Kopin One initiative is fully integrated, and automation efforts are expected to enhance efficiency and throughput in the manufacturing process [40][41] Question: Clarification on pilot aviation heads-up display issue? - The decrease in military revenues was attributed to a timing issue in manufacturing demand, not a fundamental problem [51] Question: Insights on the medical partnership and growth? - The company is working with HMDMD on expanding its medical product pipeline, with increased requests for armored vehicle systems noted [55] Question: Revenue expectations from European markets? - The company expects to see initial revenue from Europe in 2026, with significant growth anticipated in 2027 and 2028 [63][64]

Financial Data and Key Metrics Changes - In Q3 2025, net product revenue was $21.1 million, slightly up from $20.9 million in Q2 2025, with deferred revenue increasing to $7.6 million from $2.1 million in Q2 2025 [28][29] - Cost of sales for Q3 2025 totaled $28.6 million, while research and development expenses decreased to $27.9 million from $40.3 million in the same period of 2024 [29][30] - Selling, general, and administrative expenses rose to $36.3 million from $27.3 million in Q3 2024, resulting in a loss from operations of $71.6 million compared to $67.9 million in Q3 2024 [30][31] - The net loss for Q3 2025 was $79.1 million, reduced from $82.1 million in Q3 2024 [31] Business Line Data and Key Metrics Changes - The launch of AUCATZYL in the U.S. achieved $21.1 million in net sales for Q3 2025, with total sales of $51 million for the first nine months of 2025 [8][28] - The manufacturing success rate exceeded 90%, and patient access was achieved for over 90% of U.S. covered lives [9][10] Market Data and Key Metrics Changes - The CAR-T market share for the treatment of relapsed refractory B-cell ALL was approximately 20% within the 60 treatment centers currently active, indicating substantial growth potential [10][56] - The company aims to expand its geographic footprint and minimize travel distances for patients to access therapy [9] Company Strategy and Development Direction - The company is focusing on driving market share in ALL, improving margins, and expanding beyond ALL into pediatric ALL, lupus nephritis, and progressive multiple sclerosis [8][19] - The management is optimizing operations and leveraging investments made in infrastructure to drive efficiencies [7][17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing commercial launch of AUCATZYL, highlighting positive feedback from physicians and interest in investigator-sponsored trials [5][6] - The company anticipates significant growth opportunities in the CAR-T market and is preparing for upcoming data presentations at ASH [10][32] Other Important Information - The company has made key leadership changes to enhance its operational capabilities, including the appointment of a new Chief Technology Officer and Chief Commercial Officer [12][13] - The company is well-capitalized with $367.4 million in cash and marketable securities as of September 30, 2025, to support its commercialization efforts [31] Q&A Session Summary Question: Can you talk about the patient flow and anticipated patient flow going forward? - Management noted a good proportion of patients were not initially considered for CAR-T therapy, indicating an expansion of market penetration [34][35] Question: What is the competitive positioning for OB/Cell in pediatric patients? - The focus is on high-risk pediatric patients who are not eligible for CAR-T therapy, emphasizing the product's good safety and efficacy profile [37][38] Question: Can you provide insights on the Q3 performance and expected trends for Q4? - Management indicated that the Q3 performance was impacted by CMS reimbursement policy changes, but a healthy amount of deferred revenue suggests a positive outlook for Q4 [44][46] Question: What are the expected data presentations at ASH? - Key data points from the pediatric ALL study and the Carlyle study will be presented, focusing on safety, efficacy, and long-term outcomes [66][68]

Financial Data and Key Metrics Changes - The company achieved revenue of $110.5 million, representing an 8% year-over-year growth [16] - Contribution ex-TAC was $51 million, up 7% year-over-year, maintaining a healthy 46% margin [16] - Adjusted EBITDA increased 63% year-over-year to $12.1 million, reflecting improved operational leverage [15][22] - Non-GAAP net income was $12.5 million, resulting in a non-GAAP diluted earnings per share of $0.28, a 22% year-over-year increase [23] Business Line Data and Key Metrics Changes - CTV revenue grew 75% year-over-year, driven by strong demand for advanced formats [18] - Digital Out-of-Home revenue increased by 26% year-over-year, reaching 22% of total revenue [20] - Retail media revenue was up 40% year-over-year, indicating strong momentum in this vertical [20] - Web revenue declined by 11% year-over-year due to lower advertiser appetite for standard display and video formats [21] Market Data and Key Metrics Changes - CTV and Digital Out-of-Home combined represented 37% of total revenue, up from 28% in the same quarter last year [20] - The retail media market is projected to expand at a 14.7% CAGR through 2029, presenting significant growth opportunities [20] Company Strategy and Development Direction - The company is focused on becoming the platform of choice for modern CMOs, unifying media, data, and outcomes through the Perion One strategy [5][6] - New products like Outmax and SODA are designed to enhance performance-driven advertising and optimize monetization for publishers [4][9] - The company is expanding its share repurchase program to $200 million, reflecting confidence in long-term value [3][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to meet guidance for Q4, indicating no slowdown in advertiser spending [31] - The company aims to capture more market share in 2026 and beyond, with expectations for continued growth in core areas [38][39] - The operational efficiency initiatives are expected to fully materialize in 2026, supporting sustained growth [15][23] Other Important Information - The company has a strong cash position of $315 million, providing financial flexibility for growth and capital allocation [24] - The share buyback program has repurchased a cumulative total of 10.4 million shares for $94.2 million, underscoring confidence in the company's value proposition [24][25] Q&A Session Summary Question: What are the drivers behind the CTV strength in Q3? - Management noted that performance CTV and the new algorithm Outmax are driving significant growth, with a healthy pipeline of deals [31] Question: Why is the Q4 guidance range wide? - Management indicated that the quarter is trending in line with expectations, and they feel confident about delivering within the guidance range [31][32] Question: How is the web business trending relative to expectations? - Management stated that the web business performed as expected, with declines primarily due to the exit from low-margin activities [51] Question: What is the outlook for 2026 growth? - Management did not provide specific guidance for 2026 but expressed confidence in outperforming market expectations [38] Question: How is the company using AI internally? - Management highlighted that AI is integral to R&D and operational efficiency, with a focus on reducing manual work through automation [60] Question: How much of the web decline is structural versus self-inflicted? - Management clarified that approximately 13% of the web decline was due to strategic actions taken, suggesting a potential for growth in the future [64]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 was $21.1 million, a decrease of 16% from $25.2 million in Q3 2024 [18] - Net income for Q3 2025 was $9.3 million, compared to $3.4 million in the same period of 2024 [21] - Gross profit was $11.3 million in Q3 2025, down from $12.2 million in Q3 2024, but gross margins improved to 53.6% from 48.4% [20][21] - Revenue from services was $17 million, a slight decrease of 1.4% from $17.3 million in Q3 2024, contributing 80.6% of total revenue [19] Business Line Data and Key Metrics Changes - GlocalMe LINE business line saw average monthly active terminals reach 3,903, an increase of 408.2% year-over-year [7] - GlocalMe IoT recorded a year-over-year increase of 583.0% in average monthly active terminals [9] - GlocalMe SYNC surpassed 400,000 cumulative cars sold, with a 269.5% year-over-year increase in average monthly active terminals [10] - Average monthly active users (MAUs) for GlocalMe IoT, GlocalMe SYNC, and GlocalMe Life increased by 593.3%, 188.2%, and 382.3%, respectively [18] Market Data and Key Metrics Changes - Geographically, revenue contributions in Q3 2025 were 33.2% from Japan, 35.1% from Mainland China, 15.4% from North America, and 16.3% from other regions [19] - The company reported a significant increase in revenue from Mainland China, driven by the recovery of Chinese outbound travel post-pandemic [32][34] Company Strategy and Development Direction - The company is focused on overcoming digital divides through innovative connectivity solutions, including investments in R&D and marketing [6] - New product lines such as GlocalMe LINE, GlocalMe SYNC, and GlocalMe IoT are expected to drive future growth [6][14] - The company plans to establish a new operational structure and raise additional capital to accelerate the global expansion of its pet tech business [8][9] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the complex macroeconomic environment but emphasized operational profitability and stable margins [5] - For Q1 2025, the company expects total revenues to be between $22 million and $26.5 million, indicating a potential decrease of 15.4% to an increase of 1.9% compared to Q1 2024 [14] - The company is revising its full-year 2025 revenue guidance to a range of $81.3 million to $85.8 million due to ongoing macroeconomic challenges [15] Other Important Information - The company maintained a solid balance sheet with cash and cash equivalents of $28.5 million as of September 30, 2025 [22] - The average daily active terminals (DATs) were 332,674, reflecting a 3.8% increase from Q3 2024 [17] Q&A Session Summary Question: Sources of $9 million in other income - Management clarified that the $9 million gain was from the fair values of other investments, indicating a change in fair values [23] Question: Reasons for decline in product sales - Management explained that product sales decreased by $4 million, primarily due to a drop in low-margin product sales and delayed orders from a Japanese customer [24][25] Question: Drivers behind increased revenue from Mainland China - Management attributed the growth to the recovery of Chinese outbound travel and the popularity of 5G services [32][34] Question: Impact of trade tensions on the market - Management expressed optimism about the US market, anticipating growth due to new product launches and partnerships with major retailers [38] Question: Details on PetPhone orders - Management confirmed that 30,000 units of PetPhone were ordered for the Middle East market, with the remaining units allocated for the US market [48][49]

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $110.5 million, representing an 8% year-over-year growth [16] - Contribution ex-TAC was $51 million, up 7% year-over-year, maintaining a healthy 46% margin [16][22] - Adjusted EBITDA increased 63% year-over-year to $12.1 million, reflecting improved operational leverage [15][22] - Non-GAAP net income was $12.5 million, resulting in a non-GAAP diluted earnings per share of $0.28, a 22% year-over-year increase [23] Business Line Data and Key Metrics Changes - CTV revenue grew 75% year-over-year, driven by demand for advanced formats [18] - Digital out-of-home revenue increased by 26% year-over-year, reaching 22% of total revenue [20][21] - Retail media revenue was up 40% year-over-year, indicating strong momentum in this vertical [20] - Web revenue declined by 11% year-over-year due to lower advertiser appetite for standard display and video formats [21] Market Data and Key Metrics Changes - CTV and digital out-of-home combined represented 37% of total revenue, up from 28% in the same quarter last year [20] - Retail media in the US is projected to be a $60 billion opportunity, growing at double-digit annual rates [7] - The overall market for digital advertising is expected to continue shifting towards CTV and closed gardens like Meta and TikTok [45] Company Strategy and Development Direction - The company is focused on becoming the platform of choice for modern CMOs, unifying media, data, and outcomes under the Perion One strategy [5][6] - New products like Outmax and Soda are designed to enhance performance-driven advertising and optimize monetization for publishers [4][9] - The company is expanding its share repurchase program to $200 million, reflecting confidence in long-term value [3][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to meet guidance for Q4, indicating no slowdown in advertiser spending [31][32] - The company aims to capture more market share in 2026 and beyond, with expectations for continued growth in core areas [38] - Management noted that the operational efficiency initiatives are expected to fully materialize in 2026, supporting sustainable growth [15][22] Other Important Information - The company has a strong cash position of $315 million, providing financial flexibility for growth and capital allocation [24] - The Digital Out-of-Home Player is expected to enhance revenue predictability and scalability across the fast-growing channel [10][70] Q&A Session Summary Question: What are the drivers behind CTV's 75% growth in Q3? - Management highlighted the performance of CTV and the new algorithm Outmax as key drivers, with a healthy pipeline of deals [30][31] Question: Why is the Q4 guidance range wide? - Management indicated that the guidance is conservative, reflecting the peak advertising budget season and the need for caution [36] Question: How is the web business trending relative to expectations? - Management confirmed that the web business performed as expected, with the decline primarily due to low-margin business exits [51] Question: How is AI being utilized internally? - Management stated that AI is increasingly integrated into R&D and operations, reducing the need for manual work [60] Question: What is the expected impact of the actions taken in February on web revenue? - Management clarified that approximately 13% of the 11% decline in web revenue was due to the actions taken, suggesting a potential for growth in the future [64]